Diagnostics

Blood Marker Predicts Coronary Artery Disease Incidence and Severity

Published in Blood Weekly, December 7th, 2000

Scientists from San Diego State University, California, in collaboration with Medlyte Diagnostics, Inc., and the Naval Medical Center of San Diego, California, announced study results that might lead to a simple, inexpensive blood test for predicting the presence and extent of coronary artery disease (CAD).

The results were presented during the American Heart Association 73rd Scientific Sessions, held in New Orleans, during November 2000.

The MIRF (Myocardial Ischemia Rating Function) Trial was a double-blinded study of over 300 patients designed to test the utility of measuring serum sphingolipids (a type of lipids in the blood) as predictors of CAD...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry